Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) Short Interest Update

Clinuvel Pharmaceuticals Limited (OTCMKTS:CLVLY) was the recipient of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 6,900 shares, a growth of 146.4% from the November 15th total of 2,800 shares. Based on an average daily trading volume, of 6,100 shares, the short-interest ratio is currently 1.1 days.

Clinuvel Pharmaceuticals Stock Down 5.7 %

Shares of Clinuvel Pharmaceuticals stock traded down $0.47 on Friday, hitting $7.83. The company had a trading volume of 1,300 shares, compared to its average volume of 2,834. The stock has a 50-day moving average of $9.01 and a 200-day moving average of $9.54. Clinuvel Pharmaceuticals has a twelve month low of $7.83 and a twelve month high of $11.71.

About Clinuvel Pharmaceuticals

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).